Deborah Nercolini

Pronto, Lula oficialmente foi colocado na cena do crime

Efficacy and Safety of Intravenous Antiplatelet Therapy in Acute Myocardial Infarction With Cardiogenic Shock In AMI-CS patients undergoing angiography, IV antiplatelet therapy was associated with a lower ischemic risk without an increase in major bleeding at 30 days. #Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare @JACCJournals @ACCinTouch @DrMarthaGulati @hvanspall @AndrewJSauer @mmamas1973 @AnastasiaSMihai @Hragy @biljana_parapid jacc.org/doi/10.1016/j.…

Introducing the percutaneous aorto-coronary bypass graft. The VECTOR procedure revascularizes the left main coronary artery using retrograde and antegrade steps: a retrograde wire exits the left main (distal graft), an electrosurgical wire exits the aortic root (proximal graft), a guidewire rail is created, and a stent graft is delivered from the aorta to the left main. What could possibly go wrong? ahajournals.org/doi/10.1161/CI…

Grow with @UniofOxford's MSc in Clinical Trials. The part-time, distance-learning course offers small-group tutorials & guidance from leading trialists. We're pleased to support this course as part of our commitment to increasing women in research. ndph.ox.ac.uk/study-with-us/…

@ISeropianMD No. I don't think 0.5 cc makes any difference! 🤣🤣

Bicuspid AS #TAVr w 410 mm2 annulus (larger ICD) but ca2+ spot in annulus protruding towards LVOT Disc w Team 👫 btw 23 +1 or +2 cc…and ended up w +1.5 cc ⁉️ARE WE THE ONLY ONES DOING +0.5 INCREASE W S3? 🤷🏻‍♂️Not the first time we go for a +0.5 or +1.5 r we alone in this 🌎?

Women Leading Heart A place to build bridges 🌉, exchange knowledge 📚, and support one another 🤝 Thank you @MerilGlobal for this initiative and for the opportunity to share our cases with this amazing group of women colleagues. @LedurPriscila @carlaagatiello1 @AlbanezTie6796 @DebbieNercolini

New #EJHF expert consensus on SMR in HF: 📌 Optimize GDMT + CRT first ✔️ then select pts for TEER/transcatheter options. New RCTs📊 may shift indications ow.ly/Vf8M50Xtl6e @EJHFEiC @AmrAbdin10 @GiuseppeGalati_ @HanCardiomd

Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease? Read this State-of-the-Art review in #EHJ 👉 ow.ly/Ze0p50XqmPK @RoccoMontone @ehj_ed

Get this: Coffee suppressed atrial fibrillation! Unexpected results for recurrence from a randomized trial in participants after cardioversion from AF #AHA25 @JAMA_current ☕️ jamanetwork.com/journals/jama/…

@gunsnrosesgirl3 1

Which flooring goes best with the cabinets & countertop

New in #JACCINT: “New-Onset Conductance Disturbances After Transcatheter Tricuspid Valve Replacement.” This study reports a 44% incidence of conduction disturbances post-TTVR, linked to hyperdynamic RV function and device–membranous septum. bit.ly/47B38dr

Heart failure improvement, remission, and recovery: A European Journal of Heart Failureexpert consensus document The concept of HF with improved ejection fraction (HFimpEF) underscores this complexity, identifying patients who exhibit an increase in left ventricular ejection fraction (LVEF) following time and/or pharmacological and device-based therapies. #Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare @gcfmd @SJGreene_md @JavedButler1 @AndrewJSauer @ankeetbhatt @hvanspall @DrMarthaGulati @hfcollaboratory @GMCRosano @HFA_President @ onlinelibrary.wiley.com/doi/abs/10.100…

This is a truly historic moment. The results from this pivotal trial evaluating a fully percutaneous transcatheter mitral valve replacement technology has opened a new treatment option for patients who are not good candidates for surgery or TEER. This is a remarkable milestone that will not only transform the field of interventional cardiology but, most importantly, will change the lives of countless patients who have been waiting for a viable treatment option. Slides presented as LBCT #TCT2025 today and link to our manuscript published @TheLancet today are included. Thank you to all the people who worked with us for a decade to make this happen! @DVDaniels @MayoClinicCV authors.elsevier.com/a/1l-xyV-4XSjay

Trem dos Andes, chegando a 4.220 metros de altitude. Da série: Advogado diz que trem não sobe morro.

For more than 50 years, environmentalists have issued apocalyptic warnings — from famine and resource exhaustion to societal collapse — that have consistently proven false. This history of failed doomsaying should inform today’s climate debate. Sensible environmental progress has come not from alarmism but from innovation, growth, and smart policy. My new op-ed in today's New York Post: nypost.com/2025/09/15/opi…

Excelente resumo das atualizações das diretrizes de valvopatias instagram.com/reel/DOBjLuxjd…

2025 ESC/EACTS Guidelines for the management of valvular heart disease: @ESC_Journals 🥸Few highlights - dense document, please read full document for details. 😱 Summary 👇👇👇

New in #JACCINT: International cohort 🌍 of severe AS pts shows BAV-0 after #TAVR had better 5-year survival 📈 vs BAV-1 & TAV. Valve choice matters: self-expanding valves outperformed balloon-expandable valves for long-term outcomes ⏳✅ jacc.org/doi/10.1016/j.… #vhdAS

🔴 Patent Foramen Ovale & Stroke @JAMANetwork #Cardiology #Neurology #stroke